Skip to content
Open in App
Cipla logo

Cipla

web2

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes p...

Symbol · CIPL
Company profile

About

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeBSEPrimary symbol: CIPL
ExchangeNSEPrimary symbol: CIPL
Expert coverage

1 expert evaluated Cipla.

Orbitrum research

Experts evaluating Cipla

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment